The Cigna Group vs Johnson & Johnson
CI vs JNJ — side-by-side comparison from reported financials. CI leads 6, JNJ leads 4 of 10 comparable metrics.
The Cigna Group
CI · Healthcare
$282.43+0.50%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | CI | JNJ |
|---|---|---|
| Price | $282.43 | $261.79 |
| Market cap | $74.6B | $631B |
| Revenue (TTM) | $282B | $97.9B |
| Revenue growth | +15.1% | +5.6% |
| Net margin | 2.3% | 21.5% |
| Free cash flow | $10.3B | $22.2B |
| Net cash (debt) | ($22.7B) | ($27.8B) |
| 1-year price return | -7.7% | +37.0% |
| P/E | 11.6 | 29.9 |
| P/E vs own history (cheap-side %) | 80% | 16% |
| Dividend yield | 2.18% | 2.00% |
| Return on equity | 15% | 26% |
| Altman Z-score | 1.77 | — |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 67,700 | 140,800 |
Full résumé-style profiles: CI CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.